ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 104 filers reported holding ALX ONCOLOGY HLDGS INC in Q2 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $170,000 | -37.7% | 20,953 | +29.6% | 0.07% | -49.3% |
Q1 2022 | $273,000 | +23.0% | 16,165 | +56.6% | 0.14% | -35.5% |
Q4 2021 | $222,000 | -70.5% | 10,324 | +1.3% | 0.22% | -55.5% |
Q3 2021 | $753,000 | -17.4% | 10,190 | -38.9% | 0.49% | +24.2% |
Q2 2021 | $912,000 | – | 16,684 | – | 0.39% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
venBio Partners LLC | 9,699,925 | $530,392,000 | 62.60% |
Logos Global Management LP | 3,156,981 | $172,624,000 | 14.51% |
Vivo Capital, LLC | 4,220,048 | $230,752,000 | 9.99% |
Foresite Capital Management V, LLC | 231,200 | $12,642,000 | 4.97% |
Cormorant Asset Management, LP | 889,454 | $48,635,000 | 1.65% |
Board of Trustees of The Leland Stanford Junior University | 259,982 | $14,216,000 | 1.33% |
Redmile Group, LLC | 914,035 | $49,979,000 | 0.74% |
SPHERA FUNDS MANAGEMENT LTD. | 192,728 | $10,538,000 | 0.71% |
Financial Advisory Group | 54,041 | $2,955,000 | 0.71% |
Nan Fung Group Holdings Ltd | 34,950 | $1,911,000 | 0.59% |